Clinical And Regulatory RisksRisks include potential failure or equivocal data in Phase 3 trials and failure to secure regulatory approval.
Clinical Trial ProgressThe company has moderated its price target due to an updated timeline for the Phase 3 trials start.
Regulatory And Commercial RisksRisks include potential failure in the Phase 3 trial, challenges in securing regulatory approval, and the possibility of a smaller than anticipated commercial opportunity.